bdb vs itacitinib
Mechanistic comparison of bdb us9663526 example 36 us10463675 example 36 us10980815 ex no 36 us11197867 exampl and itacitinib based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
4
Shared Targets
57%
Jaccard Similarity
53%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
bdb and itacitinib share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.571 means 57% of the combined target set is bound by both compounds. The IDF-weighted score of 0.534 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.